Literature DB >> 33563965

TGR5-HNF4α axis contributes to bile acid-induced gastric intestinal metaplasia markers expression.

Zhen Ni1,2, Yali Min3, Chuan Han4, Ting Yuan5, Wenquan Lu6, Hassan Ashktorab7, Duane T Smoot8, Qiong Wu1, Jian Wu1, Weizheng Zeng2, Yongquan Shi9.   

Abstract

Intestinal metaplasia (IM) increases the risk of gastric cancer. Our previous results indicated that bile acids (BAs) reflux promotes gastric IM development through kruppel-like factor 4 (KLF4) and caudal-type homeobox 2 (CDX2) activation. However, the underlying mechanisms remain largely elusive. Herein, we verified that secondary BAs responsive G-protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5) was increased significantly in IM specimens. Moreover, TGR5 contributed to deoxycholic acid (DCA)-induced metaplastic phenotype through positively regulating KLF4 and CDX2 at transcriptional level. Then we employed PCR array and identified hepatocyte nuclear factor 4α (HNF4α) as a candidate mediator. Mechanically, DCA treatment could induce HNF4α expression through TGR5 and following ERK1/2 pathway activation. Furthermore, HNF4α mediated the effects of DCA treatment through directly regulating KLF4 and CDX2. Finally, high TGR5 levels were correlated with high HNF4α, KLF4, and CDX2 levels in IM tissues. These findings highlight the TGR5-ERK1/2-HNF4α axis during IM development in patients with BAs reflux, which may help to understand the mechanism underlying IM development and provide prospective strategies for IM treatment.

Year:  2020        PMID: 33563965     DOI: 10.1038/s41420-020-0290-3

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  51 in total

1.  Duodenogastric reflux is associated with antral metaplastic gastritis.

Authors:  M Nakamura; K Haruma; T Kamada; M Mihara; M Yoshihara; M Imagawa; G Kajiyama
Journal:  Gastrointest Endosc       Date:  2001-01       Impact factor: 9.427

Review 2.  Gastric intestinal metaplasia revisited: function and regulation of CDX2.

Authors:  Rita Barros; Jean-Noël Freund; Leonor David; Raquel Almeida
Journal:  Trends Mol Med       Date:  2012-08-04       Impact factor: 11.951

3.  Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.

Authors:  Hai-Ning Chen; Zhu Wang; Xiao Li; Zong-Guang Zhou
Journal:  Gastric Cancer       Date:  2015-01-22       Impact factor: 7.370

4.  Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer.

Authors:  Peng Zhang; Mingran Yang; Yiding Zhang; Shuai Xiao; Xinxing Lai; Aidi Tan; Shiyu Du; Shao Li
Journal:  Cell Rep       Date:  2019-05-07       Impact factor: 9.423

5.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 6.  Host-bacterial interactions in Helicobacter pylori infection.

Authors:  Manuel R Amieva; Emad M El-Omar
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

7.  Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases.

Authors:  Takeshi Matsuhisa; Tetsuo Arakawa; Tetsuo Watanabe; Tadashi Tokutomi; Kouichi Sakurai; Seisuke Okamura; Shinji Chono; Tomoari Kamada; Atsushi Sugiyama; Yoshinori Fujimura; Kenji Matsuzawa; Masanori Ito; Mitsugu Yasuda; Hiroyoshi Ota; Ken Haruma
Journal:  Dig Endosc       Date:  2013-01-29       Impact factor: 7.559

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.

Authors:  Ting Li; Hanqing Guo; Hong Li; Yanzhi Jiang; Kun Zhuang; Chao Lei; Jian Wu; Haining Zhou; Ruixue Zhu; Xiaodi Zhao; Yuanyuan Lu; Chongkai Shi; Yongzhan Nie; Kaichun Wu; Zuyi Yuan; Dai-Ming Fan; Yongquan Shi
Journal:  Gut       Date:  2019-01-11       Impact factor: 23.059

10.  Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population.

Authors:  Huan Song; Isabella Guncha Ekheden; Zongli Zheng; Jan Ericsson; Olof Nyrén; Weimin Ye
Journal:  BMJ       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.